Varewijck AJ - Search Results

1

The IGSF1 deficiency syndrome: characteristics of male and female patients.

Joustra SD, Schoenmakers N, Persani L, Campi I, Bonomi M, Radetti G, Beck-Peccoz P, Zhu H, Davis TM, Sun Y, Corssmit EP, Appelman-Dijkstra NM, Heinen CA, Pereira AM, Varewijck AJ, Janssen JA, Endert E, Hennekam RC, Lombardi MP, Mannens MM, Bak B, Bernard DJ, Breuning MH, Chatterjee K, Dattani MT, Oostdijk W, Biermasz NR, Wit JM, van Trotsenburg AS. Joustra SD, et al. Among authors: varewijck aj. J Clin Endocrinol Metab. 2013 Dec;98(12):4942-52. doi: 10.1210/jc.2013-2743. Epub 2013 Oct 9. J Clin Endocrinol Metab. 2013. PMID: 24108313

2

IGF-I bioactivity might reflect different aspects of quality of life than total IGF-I in GH-deficient patients during GH treatment.

Varewijck AJ, Lamberts SW, Neggers SJ, Hofland LJ, Janssen JA. Varewijck AJ, et al. J Clin Endocrinol Metab. 2013 Feb;98(2):761-8. doi: 10.1210/jc.2012-2901. Epub 2013 Jan 7. J Clin Endocrinol Metab. 2013. PMID: 23295465

3

IGF-I bioactivity better reflects growth hormone deficiency than total IGF-I.

Varewijck AJ, Lamberts SW, Uitterlinden P, Hofland LJ, Janssen JA. Varewijck AJ, et al. J Clin Endocrinol Metab. 2011 Jul;96(7):2248-54. doi: 10.1210/jc.2011-0051. Epub 2011 May 11. J Clin Endocrinol Metab. 2011. PMID: 21565786

4

The introduction of the IDS-iSYS total IGF-1 assay may have far-reaching consequences for diagnosis and treatment of GH deficiency.

Varewijck AJ, Lamberts SW, van der Lely AJ, Neggers SJ, Hofland LJ, Janssen JA. Varewijck AJ, et al. J Clin Endocrinol Metab. 2015 Jan;100(1):309-16. doi: 10.1210/jc.2014-2558. J Clin Endocrinol Metab. 2015. PMID: 25337924

5

Disagreement in normative IGF-I levels may lead to different clinical interpretations and GH dose adjustments in GH deficiency.

Varewijck AJ, van der Lely AJ, Neggers SJCMM, Hofland LJ, Janssen JAMJL. Varewijck AJ, et al. Clin Endocrinol (Oxf). 2018 Mar;88(3):409-414. doi: 10.1111/cen.13491. Epub 2017 Oct 24. Clin Endocrinol (Oxf). 2018. PMID: 28977695

6

Insulin analogs and cancer: a note of caution.

Janssen JA, Varewijck AJ. Janssen JA, et al. Among authors: varewijck aj. Front Endocrinol (Lausanne). 2014 May 26;5:79. doi: 10.3389/fendo.2014.00079. eCollection 2014. Front Endocrinol (Lausanne). 2014. PMID: 24904529 Free PMC article. Review.

7

IGF-IR Targeted Therapy: Past, Present and Future.

Janssen JA, Varewijck AJ. Janssen JA, et al. Among authors: varewijck aj. Front Endocrinol (Lausanne). 2014 Dec 23;5:224. doi: 10.3389/fendo.2014.00224. eCollection 2014. Front Endocrinol (Lausanne). 2014. PMID: 25566194 Free PMC article. Review.

8

Insulin and its analogues and their affinities for the IGF1 receptor.

Varewijck AJ, Janssen JA. Varewijck AJ, et al. Endocr Relat Cancer. 2012 Sep 5;19(5):F63-75. doi: 10.1530/ERC-12-0026. Print 2012 Oct. Endocr Relat Cancer. 2012. PMID: 22420005 Review.

9

Circulating IgGs may modulate IGF-I receptor stimulating activity in a subset of patients with Graves' ophthalmopathy.

Varewijck AJ, Boelen A, Lamberts SW, Fliers E, Hofland LJ, Wiersinga WM, Janssen JA. Varewijck AJ, et al. J Clin Endocrinol Metab. 2013 Feb;98(2):769-76. doi: 10.1210/jc.2012-2270. Epub 2013 Jan 7. J Clin Endocrinol Metab. 2013. PMID: 23295466

10

Changes in circulating IGF1 receptor stimulating activity do not parallel changes in total IGF1 during GH treatment of GH-deficient adults.

Varewijck AJ, Lamberts SW, van der Lely AJ, Neggers SJ, Hofland LJ, Janssen JA. Varewijck AJ, et al. Eur J Endocrinol. 2015 Aug;173(2):119-27. doi: 10.1530/EJE-15-0048. Epub 2015 May 6. Eur J Endocrinol. 2015. PMID: 25947141

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters